Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives | MicrobiomeTrials← Back to trialsNCT07316621
Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-04-01Est. Completion: 2029-12-31
Enrollment target: 10,000 participants Locations- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
- AUMC, Amsterdam, Netherlands
- UMCG, Groningen, Netherlands
- Państwowy Instytut Medyczny MSWiA w Warszawie, Warsaw, Poland
- Hospital Beatriz Ângelo, Lisbon, Portugal
- Hospital da Luz Lisboa, Lisbon, Portugal
- Hospital dos Capuchos, Lisbon, Portugal
- Hospital Santa Maria, Lisbon, Portugal
- Hospital Galdakao-Usansolo, Galdakao, Spain
- Örebro University Hospital, Örebro, Sweden
Other microbiome trials you might be interested in
Crohn Disease
The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.
Dothan, United StatesEst. completion Jul 4, 2023
Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory c…
Winston-Salem, United StatesEst. completion Jan 2027